Opioid detection
    6.
    发明授权

    公开(公告)号:US10416175B2

    公开(公告)日:2019-09-17

    申请号:US15385063

    申请日:2016-12-20

    Abstract: An immunoassay method is described which detects O-desmethyltramadol only. This enables an assay of high sensitivity and specificity avoiding false positive results. The unique antibodies incorporated in the immunoassay method can be combined with antibodies which detect mitragynine to provide an assay which increases the possibility of detecting the commonly found drug combination of O-desmethyltramadol and mitragynine.

    Ritalinic Acid Immunoassay
    10.
    发明申请
    Ritalinic Acid Immunoassay 有权
    活性蛋白

    公开(公告)号:US20140242618A1

    公开(公告)日:2014-08-28

    申请号:US14186650

    申请日:2014-02-21

    CPC classification number: G01N33/5308 C07K16/44 C07K2317/33

    Abstract: The invention provides novel antibodies which specifically bind to the methylphenidate metabolite, ritalinic acid, enabling an immunoassay that can detect methyphenidate in biological samples for an extended period following its ingestion. The invention also describes novel conjugates and kits incorporating the antibodies.

    Abstract translation: 本发明提供了特异性结合哌甲酯代谢物维拉酸的新型抗体,其能够进行生物样品中甲硝酸酯在其摄入后长时间内检测的免疫测定。 本发明还描述了掺入抗体的新型缀合物和试剂盒。

Patent Agency Ranking